Drug Type Small molecule drug |
Synonyms CCT 251921, CCT251921 |
Target |
Action inhibitors |
Mechanism CDK19 inhibitors(Cyclin-dependent kinase 19 inhibitors), CDK8 inhibitors(Cyclin-dependent kinase 8 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H23ClN6O |
InChIKeyVPJXPDLMACOGIZ-UHFFFAOYSA-N |
CAS Registry1607837-31-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | Denmark | - | |
Neoplasms | Preclinical | United Kingdom | - | |
Neoplasms | Preclinical | United Kingdom | - |